Paper
Dalton Transactions
under standard conditions using Mueller-Hinton agar
medium (tested for composition and pH), as described by
M. F. S. Teixeira, E. T. G. Cavalheiro and O. Fatibello-Filho,
II Farmaco, 2003, 58, 999–1004.
NCCLS.42 The antimicrobial activities were carried out using 10 F. Belal, Electroanalysis, 1992, 4, 589.
cultures of Staphylococcus aureus as a Gram-positive bacterium 11 F. Marchetti, C. Pettinari and R. Pettinari, Coord. Chem.
and Escherichia coli as a Gram-negative bacterium. A solution
Rev., 2005, 249, 2909–2945.
of 20 mg mL−1 of each compound (free ligand, metal com- 12 J. S. Casas, M. S. García-Tasende, A. Sánchez, J. Sordo and
plexes and the standard drug tetracycline) in DMSO was pre-
A. Touceda, Coord. Chem. Rev., 2007, 251(11–12),
1561–1589.
pared for testing. Centrifuged pellets of bacteria from a 24 h
old culture containing approximately 104–106 CFU mL−1 13 S. V. Tatwawadi, A. P. Singh and K. K. Narang, Indian
(colony forming unit) were spread on the surface of Mueller
Hinton agar plates. Then the wells were seeded with 10 mL of
J. Chem., Sect. A: Inorg., Bio-inorg., Phys., Theor. Anal. Chem.,
1982, 21A(6), 644–645.
the prepared inocula to have 106 CFU mL−1. Petri plates were 14 (a) R. C. Maurya and S. Rajput, Synth. React. Inorg. Met.-
prepared by pouring 100 mL of seeded nutrient agar. DMSO
(0.1 mL) alone was used as the control under the same con-
ditions for each microorganism, subtracting the diameter of
the inhibition zone resulting with DMSO from that obtained
in each case. The antimicrobial activities could be calculated
as the mean of three replicates.
Org. Chem., 2003, 33(10), 1877–1894; (b) R. C. Maurya,
N. Chturvedi and S. K. Thakur, J. Inst. Chem., 1999, 71(6),
216–220; (c) R. C. Maurya, V. Pillai and S. Rajput, Synth.
React. Inorg. Met.-Org. Chem., 2003, 33(4), 699–716;
(d) R. C. Maurya, D. K. Shrivastava and T. Singh, J. Inst.
Chem., 1999, 71(5), 198–201; (e) R. C. Maurya and
D. D. Mishra, Synth. React. Inorg. Met.-Org. Chem., 1988,
18(2), 133–140; (f) R. C. Maurya, R. Verma and B. Shukla,
Indian J. Chem., Sect. A: Inorg., Bio-inorg., Phys., Theor. Anal.
Chem., 1999, 38(7), 730–735; (g) R. C. Maurya, J. Dubey and
B. Shukla, Synth. React. Inorg. Met.-Org. Chem., 1998, 28(7),
1159–1171; (h) R. C. Maurya, D. D. Mishra, P. K. Trivedi
and A. Gupta, Synth. React. Inorg. Met.-Org. Chem., 1994,
24(1), 17–28; (i) R. C. Maurya, D. D. Mishra and S. Pillai,
Synth. React. Inorg. Met.-Org. Chem., 1997, 27(10),
1453–1466; ( j) R. C. Maurya, D. D. Mishra and V. Pillai,
Synth. React. Inorg. Met.-Org. Chem., 1995, 25(7), 1127–1141;
(k) R. C. Maurya, D. D. Mishra and V. Pillai, Synth. React.
Acknowledgements
I thank Dr Krzysztof Radacki, Julius-Maximilians-Universität
Würzburg, Germany, for refining the crystal structure of com-
pound 3.
References
1 (a) A. Korolkovas and J. H. Burckhalter, Química Farmacêu-
tica, Guanabara Koogan, Rio de Janeiro, 1988, pp. 193–195;
(b) R. N. Brogden, Drugs, 1986, 32(Suppl. 4), 60–70;
Inorg.
Met.-Org.
Chem.,
1995,
25(1),
139–150;
(l) R. C. Maurya, D. D. Mishra, S. Mukherjee and
P. K. Trivedi, Transition Met. Chem., 1991, 16(5), 524–527.
(c) A. Wong, A. Sibbald, F. Ferrero, M. Plager, 15 N. N. Shaforostova, N. A. Skorik and E. N. Naprienko, Zh.
M. E. Santolaya, A. M. Escobar, S. Campos, S. Barragan, Neorg. Khim., 2000, 45(8), 1344–1349.
M. De Leon Gonzalez and G. L. Kesselring, Clin. Pediatr., 16 O. A. Gabrichidze, Koord. Khim., 1988, 14(12), 1632–1635.
2001, 40, 313–324.
2 H. Ergun, I. H. Ayhan and F. C. Tulunay, Gen. Pharmacol.,
1999, 33, 237–241.
17 M. G. Miles, G. Doyle, R. P. Cooney and R. S. Tobias, Spec-
trochim. Acta, Part A, 1969, 25, 1515–1526.
18 T. B. Chenskaya, M. Berghahn, P. C. Kunz, W. Frank and
W. Kläui, J. Mol. Struct., 2007, 829, 135–148.
3 C. Muriel-Villoria, E. Zungri-Telo, M. Diaz-Curiel,
M. Fernandez-Guerrero, J. Moreno, J. Puerta and P. Ortiz, 19 M. V. Marinho, L. F. Marques, R. Diniz, H. O. Stumpf,
Eur. J. Clin. Pharmacol., 1995, 48, 103–107.
L. C. Visentin, M. I. Yoshida, F. C. Machado, F. Lioret and
M. Julve, Polyhedron, 2012, 45, 1–8.
20 A. B. P. Lever, Inorganic Electronic Spectroscopy, Elsevier,
Amsterdam, 2nd edn, 1982.
21 A. Cotton and G. Wilkinson, Advanced Inorganic Chemistry,
2nd edn, 1972.
4 W. Martindale and K. Parfitt, The Complete Drug Reference,
Pharmaceutical Press, London, 32nd edn, 1999.
5 E. Zylber-Katz, L. Granit and M. Levy, Eur. J. Clin. Pharma-
col., 1992, 42, 187–191.
6 (a) S. Z. Qureshi, A. Saeed and T. Hasan, Talanta, 1989,
36(8), 869–871; (b) N. V. Pathak and I. C. Shukla, J. Indian 22 E. González, A. Rodrigue-Witchel and C. Reber, Coord.
Chem. Soc., 1983, 60, 206–207. Chem. Rev., 2007, 251, 351–363.
7 T. Perez-Ruiz, C. Martinez-Lozano, V. Tomas and 23 A. Seminara, A. Musumeci and R. P. Bonomo, Inorg. Chim.
J. Carpena, Microchem. J., 1993, 47, 296–301. Acta, 1984, 90, 9–15.
8 N. H. Eddine, F. Bressolle, B. Mandrou and H. Fabre, 24 N. T. Abdel-Ghani, M. F. Abo El-Ghar and A. M. Mansour,
Analyst, 1982, 107, 67–70. Spectrochim. Acta, Part A, 2013, 104, 134–142.
9 (a) T. Pkrez-Ruiz, C. Martinez-Lozano and V. Tomas, 25 J. A. Welleman, F. B. Hulsbergen, J. Verbiest and J. Reddijk,
J. Pharm. Biomed. Anal., 1994, 12(9), 1109–1113; J. Inorg. Nucl. Chem., 1978, 40, 143–147.
(b) L. H. Marcolino-Júnior, M. F. Bergamini, 26 R. J. Rudley and B. J. Hathaway, J. Chem. Soc., 1970, 1725–1728.
15956 | Dalton Trans., 2014, 43, 15950–15957
This journal is © The Royal Society of Chemistry 2014